Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Walter Alexander

    News

    Routine vaccinations missed by older adults during pandemic

    Author:
    Walter Alexander
    Publish date: March 5, 2021

    Another drop in the rates of adult vaccinations may have occurred due to the surge in COVID-19 infections in the fall of 2020.

    • Read More

    News

    Researchers identify four small cell lung cancer subtypes and their best therapies

    Author:
    Walter Alexander
    Publish date: February 26, 2021

    Matching baseline tumor subtypes to SCLC therapy may enhance the depth and duration of response.

    • Read More

    News

    COVID-19: Peginterferon lambda may prevent clinical deterioration, shorten viral shedding

    Author:
    Walter Alexander
    Publish date: February 10, 2021

    Activity against respiratory pathogens has been demonstrated for interferon lambda-1, a type III interferon.

    • Read More

    News

    Many ED visits may be preventable for NSCLC patients

    Author:
    Walter Alexander
    Publish date: January 19, 2021

    Overall, 24% of ED visits were deemed preventable, and 10% were considered unnecessary.

    • Read More

    News

    Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases

    Author:
    Walter Alexander
    Publish date: December 24, 2020

    Findings could lead to better monitoring of comorbidities and deeper understanding of disease burden and AD pathophysiology, the authors write.

    • Read More

    News

    In high-risk first relapse ALL, blinatumomab seen superior to consolidation chemo

    Author:
    Walter Alexander
    Publish date: December 22, 2020

    Phase 3 study shows superior event-free survival and reduced toxicities for blinatumomab versus chemotherapy....

    • Read More

    News

    Well tolerated with promising responses in ALL/LL: Venetoclax plus navitoclax plus chemotherapy

    Author:
    Walter Alexander
    Publish date: December 16, 2020

    Delayed count recovery remains a key safety concern.

    • Read More

    News

    Phase 1 study shows feasibility, safety, efficacy of STAR T cells for ALL

    Author:
    Walter Alexander
    Publish date: December 14, 2020

    STAR (synthetic T-cell receptor and antigen receptor) T-cells were reported superior to CAR T cells for acute...

    • Read More

    News

    Synthetic lethality: Triple combination is a viable strategy for B-cell malignancies

    Author:
    Walter Alexander
    Publish date: December 11, 2020

    Once-daily oral DTRM-555 shows encouraging activity in Richter’s transformation and DLBCL.

    • Read More

    News

    Highly effective in Ph-negative B-cell ALL: Hyper-CVAD with sequential blinatumomab

    Author:
    Walter Alexander
    Publish date: December 11, 2020

    Favorable MRD negativity and overall survival rates with low higher-grade toxicities suggest that reductions in...

    • Read More

    News

    Rechallenge ‘reasonable’ for some with small-cell lung cancer

    Author:
    Walter Alexander
    Publish date: December 10, 2020

    Carboplatin plus etoposide significantly prolonged progression-free survival, compared with topotecan, in patients with advanced or relapsed,...

    • Read More

    News

    Geography and behaviors linked to early-onset colorectal cancer survival in U.S. women

    Author:
    Walter Alexander
    Publish date: December 9, 2020

    Physical inactivity and lower fertility correlate modestly with early-onset colorectal cancer mortality in women.

    • Read More

    News

    Phase 1 study: Beta-blocker may improve melanoma treatment response

    Author:
    Walter Alexander
    Publish date: December 8, 2020

    “It’s exciting that an extremely inexpensive drug like propranolol that could be used in every country around the world could have an impact on...

    • Read More

    News

    Fixed duration ibrutinib/venetoclax appears feasible for some CLL/SLL patients

    Author:
    Walter Alexander
    Publish date: December 6, 2020

    After 12 cycles of ibrutinib/venetoclax, patients then randomized to placebo had 1-year disease-free survival of...

    • Read More

    News

    TNF inhibitor–induced psoriasis treatment algorithm maintains TNF inhibitor if possible

    Author:
    Walter Alexander
    Publish date: November 25, 2020

    TNFI-induced psoriasis improved or resolved with topical medications alone in 63.5% of patients.

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties